GlobeNewswire by notified

Pixium Vision announces participation in upcoming investor conferences in September 2022

Share

Pixium Vision announces participation in upcoming investor conferences in September 2022

Paris, France, September6, 2022 – 07:00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641; Mnemo: ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces today that senior management will participate in the following investor conferences during September 2022:

  • H.C. Wainwright 24th Annual Global Investment Conference, September 12 - 14, NY & Virtual

Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, to attend virtually. Registration for the conference is open here.

  • 9th Annual HealthTech Investment Forum, September 20, Basel & September 26 - 30, Virtual

Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, to attend in person and virtually. Registration for the conference is open here.

  • LSI Europe '22 Emerging Medtech Summit, September 21 -24, Hertfordshire, UK & Virtual

Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, to attend in person. Registration for the conference is open here.

  • Sofinnova Healthcare CEO Days, September 28 - 30, Syracuse, Italy

Lloyd Diamond, Chief Executive Officer, to attend in person.

  • MedInvestMedtech, AI & Digital Health Investor Conference, September 28 - 29, Virtual

Company presentations will be exhibited via live stream on Wednesday 28 and Thursday 29 September. There will be one-on-one partnering meetings for five full days from Monday 26 to Friday 30 September. Lloyd Diamond, Chief Executive Officer, and Offer Nonhoff, Chief Financial Officer, to attend virtually. Registration for the conference is open here.

To request a one-on-one meeting with Pixium Vision please contact investors@pixium-vision.com.

About Pixium Vision

Pixium Vision is creating a world of bionic vision for those who have lost their sight, enabling them to regain visual perception and greater autonomy. Pixium Vision’s bionic vision systems are associated with a surgical intervention and a rehabilitation period. Prima System sub-retinal miniature photovoltaic wireless implant is in clinical testing for patients who have lost their sight due to outer retinal degeneration, initially for atrophic dry age-related macular degeneration (dry AMD). Pixium Vision collaborates closely with academic and research partners, including some of the most prestigious vision research institutions in the world, such as Stanford University in California, Institut de la Vision in Paris, Moorfields Eye Hospital in London, Institute of Ocular Microsurgery (IMO) in Barcelona, University hospital in Bonn, and UPMC in Pittsburgh, PA. The company is EN ISO 13485 certified and qualifies as “Entreprise Innovante” by Bpifrance.

Forward-Looking Statements. This press release contains certain forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. For a discussion of risks and uncertainties which could cause the Company's actual results, financial condition, performance or achievements to differ from those contained in the forward looking statements, please refer to the Risk Factors (“Facteurs de Risques”) section of the Company’s 2021 Half-Year Financial Report and other documents the Company files with the AMF, which is available on the AMF website (www.amf- france.org) or on the Company’s website.

For more information: To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.http://www.pixium-vision.com/fr

Follow us on To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.@PixiumVision; To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.www.facebook.com/pixiumvision

To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.www.linkedin.com/company/pixium-vision

To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

Contacts

Pixium Vision
Offer Nonhoff
Chief Financial Officer
investors@pixium-vision.com
+33 1 76 21 47 68
Media Relations

LifeSci Advisors
Sophie Baumont
sophie@lifesciadvisors.com
+33 6 27 74 74 49
Investor Relations
LifeSci Advisors
Guillaume van Renterghem
gvanrenterghem@lifesciadvisors.com
+41 76 735 01 31

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Kvika banki hf.: Increase in issue of KVIKA 25 1201 GB5.12.2022 19:17:40 CET | Press release

Today Kvika banki hf. sold nominal ISK 560 million in the bond series KVIKA 25 1201 GB at the price of 100.00, a 1.25% spread over the 3M REIBOR interest rate. The bonds have a maturity of 3 years and pay interest quarterly. Following the tap issuance, the total amount issued in the series will be ISK 1,660 million. The bonds are expected to be issued and admitted to trading on Nasdaq Iceland’s sustainable debt market on 8 December 2022. The bonds will be issued under the bank’s domestic debt programme with reference to its green financing framework. For further information please contact Kvika‘s investor relations at ir@kvika.is or via tel. (+354) 540 3200.

Sweegen announces growth capital investments and manufacturing partnership ahead of Food Ingredients Europe 20225.12.2022 19:15:05 CET | Press release

Momentum from global regulatory approvals and customers’ product launches drives strong valuation and investment demand. Rancho Santa Margarita, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sweegen announced its strategic investment and partnership snapshot ahead of the FI Europe 2022, where it will exhibit zero sugar solutions in immersive food experiences, displaying consumers’ favorite foods and beverages with zero sugar solutions in Paris, France, Dec. 6-8. In the wake of the 2022 company developments of major customer launches, a growing global footprint, and regulatory approvals on its sweeteners and stevia technology, Sweegen is attracting major partners and moving forward with additional growth capital raised from current shareholders, Pasaca Capital and Sumitomo Chemical Co. (Sumitomo), reaching the “unicorn” status. “Our growth is meaningful in the world of sweetener innovation as we are bringing wellness solutions to food and beverage brands and consumers in new global regions

Major shareholder notification – Norges Bank5.12.2022 18:31:26 CET | Press release

GN Store Nord A/S hereby announces that on December 5, 2022, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from Norges Bank stating that on December 2, 2022 Norges Bank increased its aggregate holding of shares and financial instruments, cf. Section 38(1) and Section 39(2)(1) of the Danish Capital Markets Act, to above 5% of the share capital and voting rights in GN Store Nord A/S. For further information, please contact: Investors and analysts Anne Sofie Staunsbæk Veyhe Vice President – Investor Relations, Treasury & M&A Tel: +45 45 75 85 06 or Rune Sandager Senior Director – Investor Relations Tel: +45 45 75 92 57 Press and the media Steen Frentz Laursen Vice President, Corporate Communications Tel: +45 20 65 34 20 About GN GN facilitates communication between people through intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our passion for innovation, we leverage technologies to deliv

Ilkka Oyj – Acquisition of own shares on 5 December 20225.12.2022 18:00:00 CET | Press release

ILKKA OYJ, STOCK EXCHANGE RELEASE, 5 December 2022 at 19:00 EET IlkkaOyj – Acquisition of own shares on 5 December 2022 At Nasdaq Helsinki Ltd: Date5 December 2022Exchange transactionBuyShare trading codeILKKA2Amount, shares 1,567Average price/share, EUR3.6337Total cost, EUR3,633.70 The company holds a total of 1,567 of its own shares (ILKKA2) including the shares acquired on 5 December 2022. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.com Attachment Ilkka buyback 5.12.2022

Beholdning af egne aktier5.12.2022 17:52:38 CET | pressemeddelelse

SELSKABSMEDDELELSE A.P. Møller - Mærsk A/S – Beholdning af egne aktier Per 30. november 2022 ejede A.P. Møller - Mærsk A/S (Selskabet) 5,03% af Selskabets aktier (171.277 A-aktier og 770,311 B-aktier) jfr. Lov om kapitalmarkeder § 31. A.P. Møller - Mærsk A/S har grundet det løbende opkøb af egne aktier i forbindelse med det nuværende aktietilbagekøbsprogram øget andelen af egne aktier og ejer nu over 5% af aktiekapitalen. Som tidligere meddelt er formålet med tilbagekøbsprogrammet at tilpasse Selskabets kapitalstruktur gennem annullering af tilbagekøbte aktier samt afdækning af forpligtelser under langsigtede incitamentsprogrammer. København, 5. december 2022 Kontaktperson: Head of Investor Relations, Sarah Spray, tlf. 3147 4170 Side 1 af 1 Vedhæftet fil Selskabsmeddelelse - Besiddelse af egne aktier